Literature DB >> 20032493

TCF7L2 rs7903146-macronutrient interaction in obese individuals' responses to a 10-wk randomized hypoenergetic diet.

Katrine Grau1, Stephane Cauchi, Claus Holst, Arne Astrup, J Alfredo Martinez, Wim H M Saris, Ellen E Blaak, Jean-Michel Oppert, Peter Arner, Stephan Rössner, Ian A Macdonald, Eva Klimcakova, Dominique Langin, Oluf Pedersen, Philippe Froguel, Thorkild I A Sørensen.   

Abstract

BACKGROUND: Transcription factor 7-like 2 (TCF7L2) rs7903146 associates with type 2 diabetes and may operate via impaired glucagon-like peptide 1 secretion, which is stimulated more by fat than by carbohydrate ingestion.
OBJECTIVE: The objective was to examine the interaction between TCF7L2 rs7903146 and dietary fat and carbohydrate [high-fat, low-carbohydrate: 40-45% of energy as fat (HF); compared with low-fat, high-carbohydrate: 20-25% of energy as fat (LF)] in obese individuals' responses to a 10-wk hypoenergetic diet (-600 kcal/d).
DESIGN: European, obese participants (n = 771) were randomly assigned to receive an HF or an LF diet. Body weight, fat mass (FM), fat-free mass (FFM), waist circumference (WC), resting energy expenditure (REE), fasting fat oxidation in percentage of REE (FatOx), homeostasis model assessed insulin release (HOMA-beta), and HOMA-insulin resistance (HOMA-IR) were determined at baseline and after the intervention; 739 individuals were genotyped for rs7903146.
RESULTS: Average weight loss was 6.9 kg with the LF and 6.6 kg with the HF (difference between diets, NS) diet. Among individuals who were homozygous for the T-risk allele, those in the HF diet group experienced smaller weight losses (Deltaweight) (2.6 kg; P = 0.009; n = 622), smaller DeltaFFM (1.6 kg; P = 0.027; n = 609), smaller DeltaWC (3.3 cm; P = 0.010; n = 608), and a smaller DeltaHOMA-IR (1.3 units; P = 0.004; n = 615) than did the LF diet group. For C allele carriers, there were no differences between the HF and LF diet groups. For the HF diet group, each additional T allele was associated with a reduced loss of FM (0.67 kg; P = 0.019; n = 609). TCF7L2 rs7903146 was not associated with DeltaREE, DeltaFatOx, DeltaHOMA-beta, or dropout.
CONCLUSION: Our results suggest that obese individuals who are homozygous for the TCF7L2 rs7903146 T-risk allele are more sensitive to LF than to HF weight-loss diets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032493     DOI: 10.3945/ajcn.2009.27947

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  22 in total

Review 1.  Personalized weight loss strategies-the role of macronutrient distribution.

Authors:  J Alfredo Martinez; Santiago Navas-Carretero; Wim H M Saris; Arne Astrup
Journal:  Nat Rev Endocrinol       Date:  2014-10-14       Impact factor: 43.330

2.  TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention.

Authors:  Josiemer Mattei; Qibin Qi; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Am J Clin Nutr       Date:  2012-10-03       Impact factor: 7.045

3.  Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial.

Authors:  Christopher D Gardner; John F Trepanowski; Liana C Del Gobbo; Michelle E Hauser; Joseph Rigdon; John P A Ioannidis; Manisha Desai; Abby C King
Journal:  JAMA       Date:  2018-02-20       Impact factor: 56.272

4.  Genetic Determinants of Weight Loss After Bariatric Surgery.

Authors:  Martin Aasbrenn; Theresia Maria Schnurr; Christian Theil Have; Mathilde Svendstrup; Dorte Lindqvist Hansen; Dorte Worm; Marie Balslev-Harder; Mette Hollensted; Niels Grarup; Kristoffer Sølvsten Burgdorf; Henrik Vestergaard; Oluf Pedersen; Thorkild I A Sørensen; Mogens Fenger; Sten Madsbad; Torben Hansen
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 5.  Health effects of low-carbohydrate diets: where should new research go?

Authors:  Judith Wylie-Rosett; Karin Aebersold; Beth Conlon; Carmen R Isasi; Natania W Ostrovsky
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

6.  Mediterranean Diet Adherence Modulates Anthropometric Measures by TCF7L2 Genotypes among Puerto Rican Adults.

Authors:  Mercedes Sotos-Prieto; Caren E Smith; Chao-Qiang Lai; Katherine L Tucker; José M Ordovas; Josiemer Mattei
Journal:  J Nutr       Date:  2020-01-01       Impact factor: 4.798

Review 7.  Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review.

Authors:  Glenn E Palomaki; Stephanie Melillo; Michael Marrone; Michael P Douglas
Journal:  Genet Med       Date:  2013-03-14       Impact factor: 8.822

8.  FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial.

Authors:  Xiaomin Zhang; Qibin Qi; Cuilin Zhang; Steven R Smith; Frank B Hu; Frank M Sacks; George A Bray; Lu Qi
Journal:  Diabetes       Date:  2012-08-13       Impact factor: 9.461

9.  Dietary Macronutrient Intake May Influence the Effects of TCF7L2 rs7901695 Genetic Variants on Glucose Homeostasis and Obesity-Related Parameters: A Cross-Sectional Population-Based Study.

Authors:  Witold Bauer; Edyta Adamska-Patruno; Urszula Krasowska; Monika Moroz; Joanna Fiedorczuk; Przemyslaw Czajkowski; Dorota Bielska; Maria Gorska; Adam Kretowski
Journal:  Nutrients       Date:  2021-06-04       Impact factor: 5.717

10.  TFAP2B influences the effect of dietary fat on weight loss under energy restriction.

Authors:  Tanja Stocks; Lars Angquist; Karina Banasik; Marie N Harder; Moira A Taylor; Jörg Hager; Peter Arner; Jean-Michel Oppert; J Alfredo Martinez; Jan Polak; Francis Rousseau; Dominique Langin; Stephan Rössner; Claus Holst; Ian A MacDonald; Yoichiro Kamatani; Andreas F H Pfeiffer; Marie Kunesova; Wim H M Saris; Torben Hansen; Oluf Pedersen; Arne Astrup; Thorkild I A Sørensen
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.